Functionalized graphene oxide and methods of producing the same
US-2015361089-A1 · Dec 17, 2015 · US
US10160768B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10160768-B2 |
| Application number | US-201515501658-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 4, 2015 |
| Priority date | Aug 4, 2014 |
| Publication date | Dec 25, 2018 |
| Grant date | Dec 25, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to stereochemically defined polypropionates and methods for preparing and using the same. The stereochemically defined polypropionates may be useful in the synthesis of natural products and/or natural product-like libraries.
Opening claim text (preview).
We claim: 1. A process for preparing a compound of Formula 1: comprising the steps of: reacting 6,8-dimethyl-3,9-dioxatricyclo[3.3.1.0 2,4 ]nonan-7-one with a reducing agent to form an intermediate having the following structure: and reacting the intermediate with an acid to form the compound of Formula 1. 2. A process for resolving enantiomers of a compound of Formula 1: comprising the steps of: reacting the racemic compound of Formula 1 with phthalic anhydride to form a racemic mixture of phthalates of Formulas 2A and 2B having the structure: reacting the racemic mixture of phthalates of Formulas 2A and 2B with a first chiral amine in a solvent to form a pair of diastereomeric salts thereof in a solution; precipitating a first diastereomeric salt of the pair of diastereomeric salts from the solution to provide an isolated first diastereomeric salt and an second diastereomeric salt; and forming the enantiomers of the compound of Formula 1 from the isolated first diastereomeric salt and the second diastereomeric salt, thereby resolving the enantiomers of the compound of Formula 1″. 3. The process of claim 2 , wherein the isolated first diastereomeric salt is treated with a base to form a first enantiomeric compound of Formula 1. 4. The process of claim 3 , wherein the first enantiomeric compound of Formula 1 is the compound of Formula 1B: or a salt thereof. 5. The process of claim 2 , further comprising the steps of: acidifying the second diastereomeric salt to form a free phthalate; reacting the free phthalate with a second chiral amine to reform the second diastereomeric salt in a solution; precipitating the second diastereomeric salt from the solution to form an isolated second diastereomeric salt; and forming a second enantiomeric compound of Formula 1 from the isolated second diastereomeric salt. 6. The process of claim 5 , wherein the second enantiomeric compound of Formula 1 is the compound of Formula 1A
in which the condensed system contains four or more hetero rings · CPC title
Bridged systems · CPC title
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom · CPC title
Bridged systems · CPC title
Separation of optically-active compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.